Longenesis news

Biotech and genomics companies Longenesis and Dante Genomics launch more personalised genomic services to more than 10,000 people across the Baltics and Italy, thus expanding and bridging the reach of valuable health insight delivery to patients across Europe.

Latvian Biotechnology startup Longenesis has partnered with 

Longenesis announced today the preliminary results from its study on Type 1 Diabetes care in partnership with Medtronic. In less than three months, more than 85 patients participated in the research study, providing qualitative and quantitative data on the quality of life for Type 1 diabetics using insulin pumps compared to daily insulin injections. The study sponsors used participant data to evaluate the efficiency of local reimbursement policies for insulin pumps and glucose monitors,

Women’s health platform Skrinings.lv announced today that it has partnered with multinational pharmaceutical company Gedeon Richter to launch a completely private educational platform that empowers people to make informed decisions about contraception and other birth control options. In the first two months of operations, more than 1,700 women across Northern and Western Europe have taken the test.

Launched by Longenesis and other regional healthc

In order to increase the public awareness of cardiovascular health and encourage the population to take preventive action by identifying and mitigating the effects of cardiovascular disease (CVD) risk factors in a timely fashion, the online clinic Medon in collaboration with the health technology start-up Longenesis, has published a survey to determine the CVD risk. After filling the survey, each respondent is provided with a personalized answer and recommendations from experts of the field.<

Longenesis - a digital health startup aiming towards the acceleration of the biomedical research pipeline worldwide, announced a release of its product Curator. It is a platform where clinical institutions and patient organizations are connected in consortiums with potential collaboration partners and study sponsors to initiate further cooperation. The main difference between existing solutions - ability to showcase available personalized datasets without compromising privacy.